Wednesday, March 14, 2007
Shareholders of Caremark and CVS vote later this week on the $23.4 billion merger. Proxy advisors have divided on whether to recommend that Caremark shareholders approve the acquisition. Institutional Shareholder Services recommends a yes vote, while Proxy Governance says no, citing concerns over the process. See NYTimes, Adviser Urges Caremark to Accept CVS Bid.